$AKRO stockholder filed a claim vs. Akero Therapeutics for misrepresenteing the SYMMETRY trial, its prospects, and EFX's potential as a N...

$SHLS stockholder filed a claim vs Shoals Technologies Group, Inc. for delivering substandard product. Shoals Q3’23 10-Q SEC report revea...

In March 2022, Barclays suddenly suspended issuances and sales of new VXX ETNs. On it, $VXX price rose 9.3%, causing losses to investors ...

$CO stockholder filed a claim vs. Global Cord Blood Corporation for fraudulent transactions intended to benefit insiders and related part...

$CMP stockholder filed a claim vs. Compass Minerals for overstating contract renewal prospects with the USFS and the safety testing resul...

$ADSK stockholder filed a claim vs. Autodesk for failing to disclose that it had internal control problems with its cash flow and operati...

$RIVN stockholder filed a claim vs. Rivian for overstating product demand, which impacted the order bank and 2024 targets. On February 22...

$VFS stockholder filed a claim vs. VinFast Auto (VFS) for making false statements to the SEC and the public. Between August 2023 and Janu...

$GDRX stockholder filed a claim vs. GoodRx Holdings for failing to disclose risks of losing 25% of Company's primary revenue stream. When...

$PERI stockholder filed a claim vs. Perion Network for overstating thier revenue guidance. In April, a sharp cut in revenue forecast cau...

$SHCR stockholder filed a claim vs. Sharecare for hiding setbacks in financial reporting controls. In March, news about the audit's nega...

$ASTS stockholder filed a claim vs. AST SpaceMobile for overstating satellite production and hiding suppliers' issues. On April 2, 2024,...